Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers
NCT01569347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 417
Last updated 2016-12-08
Summary
The aim of this study is to determine the clinical, genetic and environmental factors associated with the phenotype "severe psychotic symptoms" caused by cocaine.
Conditions
- Cocaine-induced Psychotic Disorder During Intoxication
Interventions
- OTHER
-
Interviews
Interviews
- OTHER
-
Blood sample
Blood sample
- OTHER
-
Hair sample
Hair sample
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Florence VORSPAN, MD, MSC · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- France
Study Locations
More Related Trials
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
M-CPP and Fenfluramine in Cocaine Addicts - 3
NCT00000314 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
NCT02537873 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
NCT01067846 ·Status: COMPLETED ·Phase: NA
-
CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations
NCT06050304 ·Status: RECRUITING ·Phase: NA
-
A Contribution to the Analysis of the Phenotypic Heterogeneity in Crack/Cocaine Addiction : a Case Control Study
NCT01025219 ·Status: UNKNOWN ·Phase: NA
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
NCT00000336 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
NCT01984177 ·Status: COMPLETED
-
Pharmacological Modulation of Cocaine Effects - 1
NCT00000201 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Yohimbine on Cocaine Cue Reactivity
NCT00535002 ·Status: COMPLETED ·Phase: PHASE2
-
Lorcaserin in the Treatment of Cocaine Use Disorder
NCT03007394 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence
NCT01535937 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cocaine Abuse and ADHD - 10
NCT00000275 ·Status: COMPLETED ·Phase: PHASE2
-
Early Phase II Trials for Cocaine Medication Development - 1
NCT00000317 ·Status: COMPLETED ·Phase: PHASE2
-
Infusion Laboratory: Protocol 1 - Selegeline - 2
NCT00000337 ·Status: COMPLETED ·Phase: PHASE1
-
5HT2CR Balance in Brain Connectivity in Cocaine Dependence
NCT03921151 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Risperidone for the Treatment of Cocaine Dependence - 7
NCT00000342 ·Status: COMPLETED ·Phase: PHASE2
-
IV Cocaine Abuse: A Laboratory Model - 2
NCT00000213 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
NCT01468012 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment Outcome in CBT for Cocaine Use
NCT03538548 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)
NCT03242928 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
NCT00000217 ·Status: COMPLETED ·Phase: PHASE2
-
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
NCT00000347 ·Status: COMPLETED ·Phase: PHASE2
-
Gender Differences in Response to Cues in Cocaine Dependence
NCT00969943 ·Status: COMPLETED